2020
Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging
Mur T, Sambhu KM, Mahajan A, Payabvash S, Fernandez J, Edwards HA. Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging. American Journal Of Otolaryngology 2020, 41: 102662. PMID: 32858370, DOI: 10.1016/j.amjoto.2020.102662.Peer-Reviewed Original ResearchConceptsPET/CTLow-dose nonenhanced CTDistant metastasisChest CTNeck cancerNonenhanced CTF-fluorodeoxyglucose positron emission tomographyF-FDG PET/CTDiagnostic chest CTDistant metastatic diseaseInitiation of therapyRetrospective cohort studyPre-treatment stagingTertiary care settingSignificant differencesPositron emission tomographyMetastatic diseaseCohort studyOncologic treatmentTNM stagingInaccurate stagingNeck radiologistsCare settingsSingle patientPatientsPotential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma
Haider SP, Zeevi T, Baumeister P, Reichel C, Sharaf K, Forghani R, Kann BH, Judson BL, Prasad ML, Burtness B, Mahajan A, Payabvash S. Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma. Cancers 2020, 12: 1778. PMID: 32635216, PMCID: PMC7407414, DOI: 10.3390/cancers12071778.Peer-Reviewed Original ResearchOropharyngeal squamous cell carcinomaProgression-free survivalPositron emission tomographySquamous cell carcinomaOverall survivalC-indexRisk stratificationCell carcinomaSurvival prognosticationHPV-negative oropharyngeal squamous cell carcinomaPre-treatment PET/CTMetastatic cervical lymph nodesBaseline positron emission tomographyBaseline distant metastasesCervical lymph nodesHuman papillomavirus (HPV) statusAmerican Joint CommitteeKaplan-Meier analysisPET/CT RadiomicsHarrell's C-indexAverage C-indexPET/CTRadiomics imaging featuresCurative intentDistant metastasis
2015
Differentiation of benign from malignant cervical lymph nodes in patients with head and neck cancer using PET/CT imaging
Payabvash S, Meric K, Cayci Z. Differentiation of benign from malignant cervical lymph nodes in patients with head and neck cancer using PET/CT imaging. Clinical Imaging 2015, 40: 101-105. PMID: 26454617, DOI: 10.1016/j.clinimag.2015.09.001.Peer-Reviewed Original ResearchMeSH KeywordsDiagnosis, DifferentialFemaleFluorodeoxyglucose F18Head and Neck NeoplasmsHumansImage-Guided BiopsyLymph NodesLymphatic DiseasesLymphatic MetastasisMaleMiddle AgedMultimodal ImagingNeckPositron-Emission TomographyRadiopharmaceuticalsRetrospective StudiesSensitivity and SpecificityTomography, X-Ray ComputedConceptsHead/neck cancerCervical lymph nodesMalignant cervical lymph nodesLymph nodesNeck cancerPositron emission tomographySUV maxHigh maximum standardized uptake valueBenign cervical lymph nodesMaximum standardized uptake valueLymph node biopsyMalignant lymph nodesMalignant cervical lymphadenopathyPET/CT imagingStandardized uptake valueSUV max valuesShort-axis diameterCervical lymphadenopathyNode biopsyMalignant lymphadenopathyRetrospective studyPatientsUptake valueEmission tomographyCancer